Dr Reddy's Q3 net dips 29% to Rs.363.3 cr

  • HT Correspondent, Hindustan Times, Mumbai
  • |
  • Updated: Feb 14, 2013 22:25 IST

Drug maker Dr Reddy's Laboratories on Thursday announced a decline of 29% year-on-year in its net profit to Rs.363.3 crore for the third quarter ended December 2012 against Rs.512.96 crore a year ago.

The company's research and development expenses rose 34% to Rs.203 crore while selling general and administrative expenses were up over 11.5% at Rs.857 crore.

Its shares declined 1% to close at Rs.1,878 on the BSE.


also read

Asian markets' volatility can affect global economy: IMF's Lagarde

blog comments powered by Disqus